SEC Form 4/A · accession 0001125345-18-000014
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Eric Blasius Risser
Officer — Sr VP & Chief Business Officer
Period of report
Jan 24, 2018
Accepted (ET)
Jan 26, 2018 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 24, 2018 | M | 3,000 | $0.94 | A | 12,100 | D | |
| Common StockF1,F2,F3 | Jan 24, 2018 | S | 3,000 | $22.50 | D | 9,100 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) | $0.94 | Jan 24, 2018 | M | 3,000 | D | Sep 24, 2009 | Mar 23, 2019 | Common Stock | 3,000 | 26,497 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted 11/14/17.
- F2The Form 4, as originally filed on 1/25/18, incorrectly reported the sale price. The Form 4, as amended by this Form 4/A, correctly reports such information.
- F3The price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $22.50 to $22.51. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.